Severe COVID-19 in Patients with Immune-Mediated Rheumatic Disorders: A Case-Control Study
COVID-19 infection in patients with im-RD is associated with increased morbidity and mortality, exerting a significant burden on the healthcare system.
Authors
- Nasir Elsidig
- Ahmed Negm (ORCID: https://orcid.org/0000-0002-3849-6852)
- Mohammed Ahmed (ORCID: https://orcid.org/0009-0001-1400-6724)
- Hend AlSaidi
- Jamal Al Saleh (ORCID: https://orcid.org/0000-0002-7569-003X)
- Noura Zamani (ORCID: https://orcid.org/0009-0006-9035-0363)
- Wafae Rachidi
- Faisal Elbadawi (ORCID: https://orcid.org/0000-0003-0282-4444)
- Nasim A. Khan (ORCID: https://orcid.org/0009-0001-0934-1739)
Institutions
- Al-Azhar University (EG)
- Dubai Hospital (AE)
- University of Hassan II Casablanca (MA)
Publication Details
- Journal
- Open Access Rheumatology Research and Reviews
- Published
- 2025-04-01
- DOI
- https://doi.org/10.2147/oarrr.s510631
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AstraZeneca